Olympus has teamed up with Ultivue and Visiopharm to provide complete solutions for reagents, slide scanning, and quantitative analysis in biomarker cell phenotyping research. Leveraging the expertise of each company in linear multiplexing reagents, fast- and high-resolution multimode slide scanning, and AI-powered software assays, we have assembled a powerful set of tools to advance your discovery and preclinical digital pathology workflows.

Predicting responses to drugs, chemicals, and devices and identifying the potential of these agents to cause cancer are critical components in the safety assessment process of drug discovery. The VS200 slide scanner’s rapid digitalization of glass slides eases both toxicology and pathology research, facilitating the image analysis of organs and tissues for morphological evaluation. Using this slide scanning system as a toxicologic pathology tool, research pathologists can identify injury at the cellular, subcellular, and molecular levels to help determine the adverse effects of drugs, chemicals, and devices.